Drug intelligence / Profile preview

4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide is a synthetic small molecule belonging to the pyrazole carboxamide class. It has the molecular formula C12H11FN4O2 and a molecular weight of approximately 262.24 g/mol[1][2][6]. The compound is primarily referenced in chemical and pharmacological databases as an experimental or research molecule, with no approved medical indications or marketed formulations[6][8]. Its structure features a pyrazole core substituted with an acetylamino group at position 4 and a carboxamide linked to a para-fluorophenyl ring at position 3. While detailed pharmacological data are limited, it is classified as having potential anti-inflammatory activity and may interact with cyclin-dependent kinase pathways based on its structural class[9]. No clinical trials or therapeutic uses have been reported for this compound.

Other names
4-acetamido-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide844440-86-4UNII-U5RM7N7H82UNII-U-5RM7N7H82UNII-U 5RM7N7H82U5RM7N7H82U-5RM7N7H82U 5RM7N7H82pyrazole amide, 18

Beyond the preview

Go deeper on 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call